Invitrogen™ Human DELE Synthetic Peptide
DELE Synthetic Peptide, PEP-1445, from Invitrogen.
- Gene ID (Enter)
- 9812
- Species
- Human
- Purification method
- Purified
- Accession number
- Q14154
- Common name
- Human DELE
- Brand
- Invitrogen
DELE Synthetic Peptide, PEP-1445, from Invitrogen.
DELE Synthetic Peptide, PEP-1445, from Invitrogen.
DELE is a recently identified DAP3-binding protein that is thought to be important in the induction of death receptor-mediated apoptosis. Transfected cells that stably express DELE were found to be susceptible to apoptosis induction by TNF-Alpha and TRAIL, whereas reducing DELE expression by siRNA rescued these cells from apoptosis induction. Furthermore, the reduction of DELE expression also inhibited the activation of caspase-3, caspase-8 and caspase-9 following stimulation by TNF-Alpha, anti-Fas, or TRAIL, indicating the importance of DELE in apoptosis mediated by death receptors.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15205359 |
| Specifications | |
| Gene ID (Enter) | 9812 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q14154 |
| Common name | Human DELE |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | KIAA0141 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-1445 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |